U.S. markets open in 3 hours 28 minutes

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.62+0.17 (+1.48%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • RBC Capital: 3 Stocks to Buy With Over 50% Upside Potential
    TipRanks

    RBC Capital: 3 Stocks to Buy With Over 50% Upside Potential

    When investors are looking for fresh investment ideas, recent recommendations from Wall Street analysts can underscore compelling investment opportunities. This is where RBC Capital comes in. The investment firm has issued recommendations on 3 stocks, highlighting each based on its strong long-term growth prospects. While the firm’s analysts believe these stocks are poised to surge at least 50% in the year ahead, we wanted to get the rest of the Street’s opinion. After using TipRanks’ database,

  • Did You Miss Sangamo Therapeutics' (NASDAQ:SGMO) 69% Share Price Gain?
    Simply Wall St.

    Did You Miss Sangamo Therapeutics' (NASDAQ:SGMO) 69% Share Price Gain?

    If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...

  • Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer
    Business Wire

    Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer

    Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Prathyusha Duraibabu, CPA, MBA as Senior Vice President and Chief Financial Officer, effective June 1, 2021. Ms. Duraibabu will lead all financial activities and report to the Chief Executive Officer.